Literature DB >> 22114475

Cytotoxicity of naphthoquinones and their capacity to generate reactive oxygen species is quenched when conjugated with gold nanoparticles.

Priya Srinivas1, Chitta Ranjan Patra, Santanu Bhattacharya, Debabrata Mukhopadhyay.   

Abstract

Several reports have demonstrated the anticancer activities of plumbagin, a naphthoquinone derivative isolated from plants belonging to Plumbaginaceae family. However, to the best of our knowledge, there are no reports which describe gold nanoconjugation with plumbagin, even though plumbagin is considered to be a promising therapeutic agent. In this report, we demonstrate the fabrication and characterization of gold nanoparticles conjugated with plumbagin (AuPB) that can reduce the toxicity of the latter, and their capacity for cellular localization and generation of reactive oxygen species. The anticancer activity and ability of plumbagin to produce reactive oxygen species was studied and compared with that of bromoderivatives of 1,4 naphthoquinones such as 2-bromo-1,4-naphthoquinone (2-BNQ) and 2,3-dibromo-1, 4-naphthoquinone (2,3-DBNQ) and their gold nanoconjugates. Plumbagin and bromoderivatives of 1,4 naphthoquinones in the form of gold nanoconjugates showed reduced cytotoxicity and apoptosis compared with the pristine compounds, ie, plumbagin, 2-BNQ, and 2,3-DBNQ. Interestingly, we observed that the gold nanoparticles could quench the reactive oxygen species-generating capacity of plumbagin, 2-BNQ, and 2,3-BNQ, which is one of the main mechanisms of action of the naphthoquinones. Therefore, it can be concluded that conjugation with gold nanoparticles can reduce the cytotoxicity of these compounds.

Entities:  

Keywords:  breast cancer; gold nanoparticles; naphthoquinones; plumbagin; reactive oxygen species

Mesh:

Substances:

Year:  2011        PMID: 22114475      PMCID: PMC3215152          DOI: 10.2147/IJN.S24074

Source DB:  PubMed          Journal:  Int J Nanomedicine        ISSN: 1176-9114


  36 in total

1.  Fabrication and characterization of an inorganic gold and silica nanoparticle mediated drug delivery system for nitric oxide.

Authors:  Amitava Das; Priyabrata Mukherjee; Sumit K Singla; Praveen Guturu; Megan C Frost; Debabrata Mukhopadhyay; Vijay H Shah; Chitta Ranjan Patra
Journal:  Nanotechnology       Date:  2010-07-08       Impact factor: 3.874

2.  Quinone-induced DNA single strand breaks in rat hepatocytes and human chronic myelogenous leukaemic K562 cells.

Authors:  W A Morgan; J A Hartley; G M Cohen
Journal:  Biochem Pharmacol       Date:  1992-07-22       Impact factor: 5.858

3.  Multifunctional nanostructures based on inorganic nanoparticles and oligothiophenes and their exploitation for cellular studies.

Authors:  Alessandra Quarta; Riccardo Di Corato; Liberato Manna; Simona Argentiere; Roberto Cingolani; Giovanna Barbarella; Teresa Pellegrino
Journal:  J Am Chem Soc       Date:  2008-07-16       Impact factor: 15.419

4.  Inhibition of lysine acetyltransferase KAT3B/p300 activity by a naturally occurring hydroxynaphthoquinone, plumbagin.

Authors:  Kodihalli C Ravindra; B Ruthrotha Selvi; Mohammed Arif; B A Ashok Reddy; Gali R Thanuja; Shipra Agrawal; Suman Kalyan Pradhan; Natesh Nagashayana; Dipak Dasgupta; Tapas K Kundu
Journal:  J Biol Chem       Date:  2009-07-01       Impact factor: 5.157

5.  Molecular mechanism of the photochemical generation of gold nanoparticles in ethylene glycol: support for the disproportionation mechanism.

Authors:  Susie Eustis; Mostafa A El-Sayed
Journal:  J Phys Chem B       Date:  2006-07-27       Impact factor: 2.991

6.  Plumbagin-induced apoptosis of human breast cancer cells is mediated by inactivation of NF-kappaB and Bcl-2.

Authors:  Aamir Ahmad; Sanjeev Banerjee; Zhiwei Wang; Dejuan Kong; Fazlul H Sarkar
Journal:  J Cell Biochem       Date:  2008-12-15       Impact factor: 4.429

7.  Genotoxicity of plumbagin and its effects on catechol and NQNO-induced DNA damage in mouse lymphoma cells.

Authors:  Jemal Demma; Karl Hallberg; Björn Hellman
Journal:  Toxicol In Vitro       Date:  2008-12-16       Impact factor: 3.500

8.  Estrogen-dependent cell signaling and apoptosis in BRCA1-blocked BG1 ovarian cancer cells in response to plumbagin and other chemotherapeutic agents.

Authors:  K A Thasni; S Rakesh; G Rojini; T Ratheeshkumar; G Srinivas; S Priya
Journal:  Ann Oncol       Date:  2008-01-10       Impact factor: 32.976

9.  Menadione-induced DNA damage in a human tumor cell line.

Authors:  E O Ngo; T P Sun; J Y Chang; C C Wang; K H Chi; A L Cheng; L M Nutter
Journal:  Biochem Pharmacol       Date:  1991-10-24       Impact factor: 5.858

10.  Topoisomerase inhibitors as anti-arthritic agents.

Authors:  J K Jackson; T Higo; W L Hunter; H M Burt
Journal:  Inflamm Res       Date:  2008-03       Impact factor: 6.986

View more
  4 in total

1.  BRCA1 promoter hypermethylation in human placenta: a hidden link with β-hCG expression.

Authors:  Revathy Nadhan; Jayashree Vijaya Vaman; Satheesh Kumar Sengodan; Sreelatha Krishnakumar Hemalatha; Nirmala Chellappan; Santha Sadasivan; Aysha Pasuthottiyil Varkey; Sreelekha Yesodharan; Krishnapriya Raji Sathyanpillai; Amritha Krishna Bhuvaneswari Venugopal; Sreevidya Prameelakumari Sreenivasan; Arathi Rajan; Neetha Rajan Latha; Geetu Rose Varghese; Ratheeshkumar Thankappan; Sarada Achyutuni; Jithin Dev Sreekumar Usha; Thapasimuthu Vijayamma Anilkumar; Priya Srinivas
Journal:  Carcinogenesis       Date:  2020-07-10       Impact factor: 4.944

2.  Gold nanoparticle trapping and delivery for therapeutic applications.

Authors:  M S Aziz; Nathaporn Suwanpayak; Muhammad Arif Jalil; R Jomtarak; T Saktioto; Jalil Ali; P P Yupapin
Journal:  Int J Nanomedicine       Date:  2011-12-29

3.  Phytoconstituents with Radical Scavenging and Cytotoxic Activities from Diospyros shimbaensis.

Authors:  Per Aronsson; Joan J E Munissi; Amra Gruhonjic; Paul A Fitzpatrick; Göran Landberg; Stephen S Nyandoro; Mate Erdelyi
Journal:  Diseases       Date:  2016-01-15

4.  Propylene Glycol Caprylate-Based Nanoemulsion Formulation of Plumbagin: Development and Characterization of Anticancer Activity.

Authors:  Adrian Chrastina; John Welsh; Per Borgström; Veronique T Baron
Journal:  Biomed Res Int       Date:  2022-01-10       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.